# LianBio — Form D

LianBio of GRAND CAYMAN, E9, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-05. $3.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-04-05
- Form: D
- Accession: 0001831283-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $3.0M
- Investors: 1
- Date of first sale: 2021-03-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-394673

## Issuer

- Name: LianBio
- CIK: 0001831283
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: C/O OGIER GLOBAL (CAYMAN) LIMITED, GRAND CAYMAN, E9, KY1-9009
- Phone: 1 345 949 9876

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| TOM ANASTASIOS GIANNAKAKOS | Director | GRAND CAYMAN, E9 |
| NEIL LEO KUMAR | Director | GRAND CAYMAN, E9 |
| Konstantin Poukalov | Director | Marlton, NJ |
| ADAM LEO STONE | Director | GRAND CAYMAN, E9 |
| DEBRA ANASTASIOS YU | Executive Officer | GRAND CAYMAN, E9 |
| BING LEO LI | Director | GRAND CAYMAN, E9 |
| BING LEO LI | Executive Officer | GRAND CAYMAN, E9 |
| TASSOS LEO GIANAKAKOS | Director | GRAND CAYMAN, E9 |
| DEBRA LEO YU | Executive Officer | GRAND CAYMAN, E9 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-11-12](https://search.stillhousedata.com/formd/0001831283-20-000001) | D | $310.0M | $270.0M |

## More

- [CIK 1831283 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1831283&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001831283-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.